Skip to Content

EGFR Recombinant Proteins

EGFR Recombinant Proteins 

EGFR recombinant proteins are synthetically produced forms of the Epidermal Growth Factor Receptor (EGFR), a transmembrane tyrosine kinase receptor that is part of the ErbB family. EGFR plays a critical role in regulating cell proliferation, survival, and differentiation. Dysregulation of EGFR signaling is implicated in various cancers, including lung, colorectal, and head-and-neck cancers. 

Technical Content
  • Expression Systems:
    • Mammalian cells (e.g., HEK293, CHO): Preferred for glycosylated and full-length proteins.
    • Baculovirus-infected insect cells: Used for high-yield production of functional proteins.
    • E. coli: Suitable for non-glycosylated domains like the kinase domain.
  • Purification and Quality Control:
    • Purified via affinity chromatography using tags such as His-tag or GST-tag, followed by size-exclusion chromatography.
    • Quality validated by:
      • SDS-PAGE and Western blotting for purity and size.
      • Functional assays (e.g., kinase activity or ligand binding assays).
      • Mass spectrometry for structural integrity.
  • Variants and Mutations:
    • Recombinant EGFR proteins include cancer-relevant mutations like EGFRvIII (a constitutively active mutant) and T790M (associated with drug resistance).
Applications of EGFR Recombinant Proteins
  • Cancer Research:
    • Study the role of EGFR in tumor growth, metastasis, and angiogenesis.
    • Investigate the impact of EGFR mutations on signaling pathways and drug resistance mechanisms.
  • Drug Development and Screening:
    • Used to screen small molecule inhibitors targeting the tyrosine kinase domain (e.g., erlotinib, gefitinib).
    • Facilitate the evaluation of therapeutic antibodies (e.g., cetuximab) that block ligand binding to the extracellular domain.
  • Structural Biology:
    • Crystallographic and cryo-EM studies of EGFR domains provide insights into receptor activation and inhibitor binding.
    • Structural data are critical for designing next-generation EGFR-targeted therapies.

EGFR recombinant proteins are essential for advancing cancer research, drug discovery, and therapeutic development. Their high quality and precise engineering make them indispensable tools for studying EGFR-mediated signaling, evaluating inhibitors, and designing strategies to overcome drug resistance.

$ 600.00
$ 2,230.80
$ 600.00
$ 2,230.80
$ 2,626.80
$ 2,547.60
$ 492.00
$ 2,547.60
$ 2,494.80
$ 1,637.35
$ 607.50
$ 398.50
$ 398.50

AffiREC® Recombinant Human EGFR (C-6His)

CAT# AFG-EPR-0210
Size: 10 µg
$ 237.15

AffiREC® Recombinant Human EGFR (C-Fc)

CAT# AFG-EPR-0127
Size: 50 µg
$ 398.65